Humoral effects of perindopril in essential hypertension. 1991

G A Sagnella, and N D Markandu, and D R Singer, and M G Buckley, and M A Miller, and G A MacGregor

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000806 Angiotensin-Converting Enzyme Inhibitors A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. ACE Inhibitor,ACE Inhibitors,Angiotensin Converting Enzyme Inhibitor,Angiotensin I-Converting Enzyme Inhibitor,Angiotensin-Converting Enzyme Inhibitor,Kininase II Inhibitor,Kininase II Inhibitors,Angiotensin I-Converting Enzyme Inhibitors,Angiotensin-Converting Enzyme Antagonists,Antagonists, Angiotensin-Converting Enzyme,Antagonists, Kininase II,Inhibitors, ACE,Inhibitors, Angiotensin-Converting Enzyme,Inhibitors, Kininase II,Kininase II Antagonists,Angiotensin Converting Enzyme Antagonists,Angiotensin Converting Enzyme Inhibitors,Angiotensin I Converting Enzyme Inhibitor,Angiotensin I Converting Enzyme Inhibitors,Antagonists, Angiotensin Converting Enzyme,Enzyme Antagonists, Angiotensin-Converting,Enzyme Inhibitor, Angiotensin-Converting,Enzyme Inhibitors, Angiotensin-Converting,II Inhibitor, Kininase,Inhibitor, ACE,Inhibitor, Angiotensin-Converting Enzyme,Inhibitor, Kininase II,Inhibitors, Angiotensin Converting Enzyme
D020913 Perindopril An angiotensin-converting enzyme inhibitor. It is used in patients with hypertension and heart failure. Perindopril Erbumine,Perstarium,Pirindopril,S 9490-3,S-9490,Erbumine, Perindopril,S 9490,S 9490 3,S 94903,S9490

Related Publications

G A Sagnella, and N D Markandu, and D R Singer, and M G Buckley, and M A Miller, and G A MacGregor
October 1990, Journal of human hypertension,
G A Sagnella, and N D Markandu, and D R Singer, and M G Buckley, and M A Miller, and G A MacGregor
January 1990, Drugs,
G A Sagnella, and N D Markandu, and D R Singer, and M G Buckley, and M A Miller, and G A MacGregor
April 1992, The American journal of medicine,
G A Sagnella, and N D Markandu, and D R Singer, and M G Buckley, and M A Miller, and G A MacGregor
January 2014, Kardiologiia,
G A Sagnella, and N D Markandu, and D R Singer, and M G Buckley, and M A Miller, and G A MacGregor
December 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
G A Sagnella, and N D Markandu, and D R Singer, and M G Buckley, and M A Miller, and G A MacGregor
June 1994, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
G A Sagnella, and N D Markandu, and D R Singer, and M G Buckley, and M A Miller, and G A MacGregor
January 1963, Verhandlungen der Deutschen Gesellschaft fur Kreislaufforschung,
G A Sagnella, and N D Markandu, and D R Singer, and M G Buckley, and M A Miller, and G A MacGregor
June 2004, The Canadian journal of cardiology,
G A Sagnella, and N D Markandu, and D R Singer, and M G Buckley, and M A Miller, and G A MacGregor
July 1988, American journal of hypertension,
G A Sagnella, and N D Markandu, and D R Singer, and M G Buckley, and M A Miller, and G A MacGregor
January 1991, Journal of cardiovascular pharmacology,
Copied contents to your clipboard!